Position in DNA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,328,335
+$1,211,707 QoQ
Shares Held
134,040
+604.5% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. DNA ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in DNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,328,335 | 134,040 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $116,628 | 19,026 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $138,651 | 16,685 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $230,027 | 15,777 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $207,753 | 18,467 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $886,326 | 155,496 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,187 | 121 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $124,735 | 15,305 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $197,744 | 592,052 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $698,492 | 602,150 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,809,932 | 1,070,967 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,510,703 | 834,643 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,449,192 | 779,136 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,430,281 | 1,075,400 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2,084,198 | 1,233,254 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,478,905 | 794,521 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,288,165 | 541,246 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $10,865,395 | 2,696,128 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $9,948,241 | 1,197,141 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $313,439 | 27,044 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||